Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has informed that it enclosed disclosure of Related Party Transactions for the half year ended 30 September 2022 in pdf format. The aforesaid disclosure in XBRL mode was submitted on 16 November 2022.
The above information is a part of company’s filings submitted to BSE.